Investigating the potential effects of α-synuclein aggregation on susceptibility to chronic stress in a mouse Parkinson's disease model

被引:2
|
作者
Alwani, Anna [1 ]
Maziarz, Katarzyna [1 ]
Lyszczarz, Gabriela [1 ]
Jankowska-Kieltyka, Monika [1 ]
Roman, Adam [1 ]
Lyszczarz, Gabriela [1 ]
Er, Safak [2 ,3 ]
Barut, Justyna [1 ]
Barczyk-Woznicka, Olga [4 ]
Pyza, Elzbieta [4 ]
Kreiner, Grzegorz [1 ]
Nalepa, Irena [1 ]
Chmielarz, Piotr [1 ]
机构
[1] Polish Acad Sci, Maj Inst Pharmacol, Dept Brain Biochem, Smetna 12, PL-31343 Krakow, Poland
[2] Univ Helsinki, Drug Res Program, Fac Pharm, Helsinki, Finland
[3] Univ Helsinki, HiLIFE, Inst Biotechnol, Helsinki, Finland
[4] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Cell Biol & Imaging, Gronostajowa 9, PL-30387 Krakow, Poland
基金
芬兰科学院;
关键词
alpha-synuclein; Preformed fibrils; Parkinson's disease; Non-motor symptoms; Depression; Chronic stress; LEWY BODIES; DEPRESSIVE-LIKE; AMYGDALA; MICE; BODY; NEURODEGENERATION; COMPENSATION; PHENOTYPES; DEMENTIA; BEHAVIOR;
D O I
10.1007/s43440-023-00530-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Parkinson's disease (PD) is a motor disorder characterized by the degeneration of dopaminergic neurons, putatively due to the accumulation of alpha-synuclein (alpha-syn) in Lewy bodies (LBs) in Substantia Nigra. PD is also associated with the formation of LBs in brain areas responsible for emotional and cognitive regulation such as the amygdala and prefrontal cortex, and concurrent depression prevalence in PD patients. The exact link between dopaminergic cell loss, alpha-syn aggregation, depression, and stress, a major depression risk factor, is unclear. Therefore, we aimed to explore the interplay between sensitivity to chronic stress and alpha-syn aggregation.Methods Bilateral injections of alpha-syn preformed fibrils (PFFs) into the striatum of C57Bl/6 J mice were used to induce alpha-syn aggregation. Three months after injections, animals were exposed to chronic social defeat stress.Results alpha-syn aggregation did not affect stress susceptibility but independently caused increased locomotor activity in the open field test, reduced anxiety in the light-dark box test, and increased active time in the tail suspension test. Ex vivo analysis revealed modest dopaminergic neuron loss in the substantia nigra and reduced dopaminergic innervation in the dorsal striatum in PFFs injected groups. alpha-Syn aggregates were prominent in the amygdala, prefrontal cortex, and substantia nigra, with minimal alpha-syn aggregation in the raphe nuclei and locus coeruleus.Conclusions Progressive bilateral alpha-syn aggregation might lead to compensatory activity increase and alterations in emotionally regulated behavior, without affecting stress susceptibility. Understanding how alpha-syn aggregation and degeneration in specific brain structures contribute to depression and anxiety in PD patients requires further investigation.
引用
收藏
页码:1474 / 1487
页数:14
相关论文
共 50 条
  • [31] Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
    Changyoun Kim
    Emmanuel Ojo-Amaize
    Brian Spencer
    Edward Rockenstein
    Michael Mante
    Paula Desplats
    Wolf Wrasidlo
    Anthony Adame
    Emeka Nchekwube
    Olusola Oyemade
    Joseph Okogun
    Michael Chan
    Howard Cottam
    Eliezer Masliah
    Journal of Neuroinflammation, 12
  • [32] Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations
    Sahay, Shruti
    Ghosh, Dhiman
    Singh, Pardeep K.
    Maji, Samir K.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2017, 18 (07) : 656 - 676
  • [33] Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease
    Tatenhorst, Lars
    Eckermann, Katrin
    Dambeck, Vivian
    Fonseca-Ornelas, Luis
    Walle, Hagen
    da Fonseca, Tomas Lopes
    Koch, Jan C.
    Becker, Stefan
    Toenges, Lars
    Baehr, Mathias
    Outeiro, Tiago F.
    Zweckstetter, Markus
    Lingor, Paul
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 : 39
  • [34] Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease
    Pan, Lina
    Li, Chunrui
    Meng, Lanxia
    Tian, Ye
    He, Mingyang
    Yuan, Xin
    Zhang, Guoxin
    Zhang, Zhaohui
    Xiong, Jing
    Chen, Guiqin
    Zhang, Zhentao
    BRAIN, 2022, 145 (10) : 3454 - 3471
  • [35] α-Synuclein staging in the amygdala of a Parkinson's disease model: cell types involved
    Flores-Cuadrado, Alicia
    Ubeda-Banon, Isabel
    Saiz-Sanchez, Daniel
    de la Rosa-Prieto, Carlos
    Martinez-Marcos, Alino
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2015, 41 (01) : 137 - 146
  • [36] Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment
    Kalsoom, Iqra
    Wang, Yuanhao
    Li, Bo
    Wen, Hongliang
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (20) : 1959 - 1974
  • [37] α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis
    Mehra, Surabhi
    Sahay, Shruti
    Maji, Samir K.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2019, 1867 (10): : 890 - 908
  • [38] C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease
    Ma, Liang
    Yang, Chen
    Zhang, Xia
    Li, Yang
    Wang, Shun
    Zheng, Ling
    Huang, Kun
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (12): : 3714 - 3725
  • [39] Potential for Therapeutic-Loaded Exosomes to Ameliorate the Pathogenic Effects of α-Synuclein in Parkinson's Disease
    Rademacher, David J.
    BIOMEDICINES, 2023, 11 (04)
  • [40] Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease
    Zhou, Wenbo
    Barkow, Jessica Cummiskey
    Freed, Curt R.
    PLOS ONE, 2017, 12 (12):